FLT3 and acute myeloid leukemia: MiRNA‐155 is a crucial oncomiR in AML, and a natural product called silvestrol can inhibit colony formation and apoptosis in FLT3‐ITD‐positive (whose overexpression is relevant to poor outcome in AML) AML cell lines, which supports the clinical testing of sivestrol as a novel therapeutic approach for AML.193